miR-1305 was able to reduce the stemness of HCC CSCs by downregulating its direct target UBE2T, which is upregulated in HCC CSCs and promotes stemness via the Akt-signaling pathway [113]. Here, UBE2T is linked to hepatocellular carcinoma.